Vitamin D Endocrine System and COVID‐19

ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitam...

Full description

Saved in:
Bibliographic Details
Published inJBMR plus Vol. 5; no. 12; pp. e10576 - n/a
Main Authors Bouillon, Roger, Quesada‐Gomez, José Manuel
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2021
Oxford University Press
Subjects
25-Hydroxyvitamin D
ACUTE RESPIRATORY DISTRESS SYNDROME
CALCIFEDIOL
Clinical trials
Coronaviruses
COVID-19
Dietary supplements
Endocrine system
Health care
Inflammation
INTENSIVE CARE TREATMENT
Lymphocytes
MORTALITY
Original
Respiratory distress syndrome
Tumor necrosis factor-TNF
VITAMIN D
MORTALITY
CALCIFEDIOL
ACUTE RESPIRATORY DISTRESS SYNDROME
COVID‐19
INTENSIVE CARE TREATMENT
VITAMIN D
Online AccessGet full text

Cover

Abstract ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D‐deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti‐inflammatory and anti‐thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS‐2/COVID‐19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID‐19. Meta‐analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID‐19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID‐19, based on real‐world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID‐19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
AbstractList Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25-dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D-deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti-inflammatory and anti-thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS-2/COVID-19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID-19. Meta-analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID-19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID-19, based on real-world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID-19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25-dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D-deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti-inflammatory and anti-thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS-2/COVID-19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID-19. Meta-analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID-19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID-19, based on real-world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID-19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D‐deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti‐inflammatory and anti‐thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS‐2/COVID‐19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID‐19. Meta‐analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID‐19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID‐19, based on real‐world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID‐19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D‐deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti‐inflammatory and anti‐thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS‐2/COVID‐19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID‐19. Meta‐analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID‐19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID‐19, based on real‐world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID‐19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D‐deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti‐inflammatory and anti‐thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS‐2/COVID‐19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID‐19. Meta‐analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID‐19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID‐19, based on real‐world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID‐19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25‐dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D‐deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti‐inflammatory and anti‐thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS‐2/COVID‐19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID‐19. Meta‐analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID‐19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID‐19, based on real‐world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID‐19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and lungs can express the vitamin D receptor, and overall these cells respond in a coherent fashion when exposed to 1,25-dihydroxyvitamin D, the main metabolite of the VDES. Supplementation of vitamin D-deficient subjects may decrease the risk of upper respiratory infections. The VDES also has broad anti-inflammatory and anti-thrombotic effects, and other mechanisms argue for a potential beneficial effect of a good vitamin D status on acute respiratory distress syndrome, a major complication of this SARS-2/COVID-19 infection. Activation of the VDES may thus have beneficial effects on the severity of COVID-19. Meta-analysis of observational data show that a better vitamin D status decreased the requirement of intensive care treatment or decreased mortality. A pilot study in Cordoba indicated that admission to intensive care was drastically reduced by administration of a high dose of calcifediol early after hospital admission for COVID-19. A large observational study in Barcelona confirmed that such therapy significantly decreased the odds ratio (OR) of mortality (OR = 0.52). This was also the conclusion of a retrospective study in five hospitals of Southern Spain. A retrospective study on all Andalusian patients hospitalized because of COVID-19, based on real-world data from the health care system, concluded that prescription of calcifediol (hazard ratio [HR] = 0.67) or vitamin D (HR = 0.75), 15 days before hospital admission decreased mortality within the first month. In conclusion, a good vitamin D status may have beneficial effects on the course of COVID-19. This needs to be confirmed by large, randomized trials, but in the meantime, we recommend (rapid) correction of 25 hydroxyvitamin D (25OHD) deficiency in subjects exposed to this coronavirus. © 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Author Bouillon, Roger
Quesada‐Gomez, José Manuel
AuthorAffiliation 1 Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing KU Leuven Leuven Belgium
3 CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain
2 Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía Universidad de Córdoba, Fundación Progreso y Salud Córdoba Spain
AuthorAffiliation_xml – name: 3 CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain
– name: 1 Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing KU Leuven Leuven Belgium
– name: 2 Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía Universidad de Córdoba, Fundación Progreso y Salud Córdoba Spain
Author_xml – sequence: 1
  givenname: Roger
  orcidid: 0000-0002-6446-3763
  surname: Bouillon
  fullname: Bouillon, Roger
  email: roger.bouillon@kuleuven.be
  organization: KU Leuven
– sequence: 2
  givenname: José Manuel
  orcidid: 0000-0003-0990-5650
  surname: Quesada‐Gomez
  fullname: Quesada‐Gomez, José Manuel
  organization: CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34950831$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1OFTEYhhuDEUQ2XoCZxI2SHOz_tBsSPaAcg2Ghsm36N9iTmRbbOZqz8xK8Rq7EHgYMEOOqTft8T972fQq2YooegOcIHiAI8ZulGWjdsZY_AjuYtmRGIZFbd_bbYK-UJYQQtYIwwZ-AbUIlg4KgHfD6PIx6CLE5ao6jSzaH6JvP6zL6odHRNfOz88XR1a_fSD4DjzvdF793s-6Cr--Pv8xPZqdnHxbzt6czyxDlM6Y7TklLhdTQO2u8g4RYaAXqvJG-M1IaxDsnHea89UZDyigSlDnrpW8d2QWLyeuSXqrLHAad1yrpoK4PUr5QOo_B9l5hQxB10FWtrS-iRmpHmDFcUCyt4NV1OLkuV2aoaXwcs-7vSe_fxPBNXaQfSvCWtlxWwasbQU7fV76MagjF-r7X0adVUZgjirHkDFf05QN0mVY51q_aUJAgxrio1Iu7if5GuW2kAnACbE6lZN8pWxsaQ9oEDL1CUG16V5ve1XXvdWT_wcit9Z8wmuCfoffr_5Dq47tPdJr5AwSJuts
CitedBy_id crossref_primary_10_1007_s00253_024_13244_w
crossref_primary_10_1007_s12020_022_03208_3
crossref_primary_10_1016_j_hnm_2024_200255
crossref_primary_10_1111_joim_13536
crossref_primary_10_3390_nu14122447
crossref_primary_10_7759_cureus_42561
crossref_primary_10_5005_jp_journals_10071_24260
crossref_primary_10_3390_nu14132716
crossref_primary_10_3390_nu16050679
crossref_primary_10_3390_nu16121910
crossref_primary_10_3390_nu14051000
crossref_primary_10_3390_nu14081625
crossref_primary_10_3390_nu14020317
Cites_doi 10.1186/s12964-019-0488-2
10.1001/jama.2019.0052
10.1038/nri3787
10.1016/j.bcp.2020.113955
10.4161/auto.6787
10.1002/JLB.5HI0720-466R
10.1111/febs.15495
10.3390/nu13061760
10.1056/NEJMra070553
10.1111/cen.14540
10.1136/bmj.i6583
10.1210/clinem/dgaa733
10.1017/S0007114513001840
10.1159/000243200
10.1080/21688370.2018.1540904
10.1016/S2213-2600(20)30076-X
10.1038/s41586-018-0162-7
10.1016/j.ebiom.2020.102925
10.1186/s12967-020-02374-0
10.3390/nu12040988
10.3892/mmr.2017.7546
10.1007/s11154-019-09532-w
10.1038/s41598-021-87703-z
10.1016/S2213-8587(21)00051-6
10.1155/2020/8829674
10.1016/j.jsbmb.2020.105751
10.3390/nu7043011
10.7150/ijbs.46891
10.1172/jci.insight.140289
10.3390/nu10040409
10.1038/s41418-021-00805-z
10.1371/journal.pone.0239252
10.1016/j.bbrc.2013.06.004
10.1074/jbc.M306340200
10.1038/nrcardio.2016.73
10.1016/j.jsbmb.2004.03.004
10.1111/jth.14768
10.1002/eji.200839103
10.1136/bmj.m3379
10.3389/fimmu.2020.01137
10.1038/s41586-020-2012-7
10.1097/SHK.0b013e3182a6953e
10.1016/j.jsbmb.2004.03.054
10.1126/science.1123933
10.1210/clinem/dgab405
10.1172/JCI30142
10.3390/biom9110649
10.1074/jbc.M404865200
10.1016/j.intimp.2020.107233
10.1002/jbm4.10569
10.1007/s00109-006-0094-9
10.4049/jimmunol.1000560
10.1210/er.2012-1000
10.3892/mmr.2015.4685
10.1016/j.jaut.2017.07.007
10.1002/eji.200838216
10.3390/nu9090980
10.1165/rcmb.2014-0482OC
10.1165/rcmb.2019-0295OC
10.1371/journal.pone.0239799
10.1016/j.dsx.2020.04.050
10.1128/JVI.01782-06
10.2144/fsoa-2020-0091
10.1038/nri.2017.1
10.1183/13993003.03167-2020
10.1016/j.jsbmb.2020.105719
10.1161/01.CIR.102.23.2867
10.1186/s12931-020-01405-0
10.1513/AnnalsATS.201312-423OC
10.1038/s41467-019-13659-4
10.1038/labinvest.2012.150
10.1001/jama.2020.26848
10.3390/nu12051248
10.1172/JCI111465
10.1167/iovs.11-7605
10.1177/1076029613509477
10.1016/S2213-2600(21)00218-6
10.1016/j.jsbmb.2021.105928
10.1152/ajpgi.00398.2007
10.1038/s41598-020-80655-w
10.1038/ki.2008.101
10.1001/jama.2017.21907
10.1016/j.bbrc.2011.03.078
10.4049/jimmunol.173.5.2909
10.1371/journal.ppat.1002689
10.1002/ppul.23500
10.1016/S2213-2600(20)30603-2
10.3390/biomedicines9050509
10.1038/s41586-020-2521-4
10.1016/j.chom.2009.08.004
10.1016/j.biocel.2011.11.019
10.1210/er.2018-00126
10.1371/journal.ppat.1003407
10.1016/j.bbrc.2014.07.081
10.1016/j.coph.2010.04.001
10.1038/srep15561
10.1210/jc.2010-0195
10.1002/jbm4.10405
10.1016/S0140-6736(20)30628-0
10.1371/journal.pone.0005810
10.1007/s11239-020-02129-0
10.1210/endocr/bqaa218
10.1056/NEJMoa2015432
10.1530/EJE-20-0665
10.1096/fj.15-272872
10.1016/j.mce.2017.04.018
10.1016/j.trsl.2015.04.015
10.1016/j.micpath.2021.104930
10.1681/ASN.2013040355
10.1081/IPH-120014721
10.4049/jimmunol.170.11.5382
10.1038/ni.1851
10.1177/1076029618786574
10.1038/nature03712
10.1038/jid.2011.296
10.1038/ncomms7062
10.1016/j.metabol.2021.154753
10.1359/JBMR.050908
10.1126/science.abc6027
10.1016/j.steroids.2018.11.001
10.1002/dmrr.1275
10.1038/s41392-020-00417-y
ContentType Journal Article
Copyright 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
– notice: 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/jbm4.10576
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


CrossRef
Publicly Available Content Database

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central (New)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate VITAMIN D ENDOCRINE SYSTEM AND COVID‐19
EISSN 2473-4039
EndPage n/a
ExternalDocumentID oai_doaj_org_article_2b314d0d9efc4954b9ad35bb68429c86
PMC8674769
34950831
10_1002_jbm4_10576
JBM410576
Genre article
Journal Article
GroupedDBID 0R~
1OC
24P
7X7
8FE
8FH
8FI
8FJ
AAHHS
ABEJV
ABUWG
ABXVV
ACCFJ
ACCMX
ACXQS
ADBBV
ADKYN
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
EBS
EJD
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
IHR
INH
ITC
LK8
M7P
M~E
OK1
PIMPY
PROAC
ROX
RPM
TOX
UKHRP
WIN
AAYXX
ABGNP
AMNDL
CITATION
PHGZM
PHGZT
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
COVID
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5146-5af6437489a0edcbed033c0c81feb9efb99b16fd9d2667eba04541845dce9e7d3
IEDL.DBID 7X7
ISSN 2473-4039
IngestDate Wed Aug 27 00:54:53 EDT 2025
Thu Aug 21 14:11:49 EDT 2025
Fri Jul 11 09:00:07 EDT 2025
Wed Aug 13 09:34:05 EDT 2025
Wed Feb 19 02:07:13 EST 2025
Tue Jul 01 01:18:17 EDT 2025
Thu Apr 24 22:58:54 EDT 2025
Wed Jan 22 17:22:03 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords MORTALITY
CALCIFEDIOL
ACUTE RESPIRATORY DISTRESS SYNDROME
COVID‐19
INTENSIVE CARE TREATMENT
VITAMIN D
Language English
License Attribution
2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5146-5af6437489a0edcbed033c0c81feb9efb99b16fd9d2667eba04541845dce9e7d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0990-5650
0000-0002-6446-3763
OpenAccessLink https://www.proquest.com/docview/2610315568?pq-origsite=%requestingapplication%
PMID 34950831
PQID 2610315568
PQPubID 4370309
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_2b314d0d9efc4954b9ad35bb68429c86
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8674769
proquest_miscellaneous_2614229652
proquest_journals_2610315568
pubmed_primary_34950831
crossref_citationtrail_10_1002_jbm4_10576
crossref_primary_10_1002_jbm4_10576
wiley_primary_10_1002_jbm4_10576_JBM410576
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2021
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: December 2021
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: England
– name: Hoboken
PublicationTitle JBMR plus
PublicationTitleAlternate JBMR Plus
PublicationYear 2021
Publisher John Wiley & Sons, Inc
Oxford University Press
Publisher_xml – name: John Wiley & Sons, Inc
– name: Oxford University Press
References 2010; 11
2010; 10
2017; 85
1990; 57
2019; 10
2021; 325
2008; 38
2019; 17
2011; 52
2020; 16
2020; 203
2021; 162
2014; 25
2010; 185
2016; 30
2020; 15
2020; 14
2020; 12
2020; 287
2020; 11
2020; 202
2003; 278
2019; 321
2013; 9
2020; 18
2018; 6
2012; 132
2007; 294
2006; 21
2011; 407
2004; 173
2013; 117
2020; 579
2020; 177
2021; 155
2014; 11
2019; 9
2020; 383
2016; 167
2003; 170
2014; 46
2012; 33
2016; 13
2018; 24
2017; 52
2019; 40
2020; 2020
2004; 279
2000; 102
2020; 395
2017; 56
2007; 81
2020; 21
2018; 10
2012; 44
2020; 63
2021; 28
2020; 369
2020; 58
2020; 56
2008; 74
2008; 4
2014; 451
2017; 356
2017; 9
2020; 8
2020; 6
2020; 5
2020; 50
2013; 437
2021; 119
2020; 370
2021; 110
2011; 27
2014; 7
2021; 9
2015; 15
2021; 5
2015; 6
2015; 5
2013; 40
2021; 106
2020; 183
2005; 436
2020; 584
2014; 111
2019; 141
2017; 453
2015; 7
2021; 90
2006; 311
2021; 13
2007; 357
1984; 74
2012; 92
2007; 117
2006; 84
2021; 11
2021; 212
2021
2017; 17
2020
2017; 16
2018; 558
2002; 24
2021; 17
2015; 21
2018; 319
2009; 6
2004; 89–90
2009; 4
2010; 95
2012; 8
2009; 39
Khademvatani K (e_1_2_7_12_1) 2014; 7
e_1_2_7_108_1
e_1_2_7_3_1
e_1_2_7_104_1
e_1_2_7_127_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_60_1
e_1_2_7_83_1
e_1_2_7_100_1
e_1_2_7_123_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_64_1
e_1_2_7_87_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_68_1
e_1_2_7_26_1
e_1_2_7_49_1
e_1_2_7_116_1
e_1_2_7_90_1
e_1_2_7_112_1
e_1_2_7_94_1
e_1_2_7_52_1
e_1_2_7_98_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_75_1
e_1_2_7_56_1
e_1_2_7_37_1
e_1_2_7_79_1
e_1_2_7_131_1
e_1_2_7_109_1
e_1_2_7_4_1
e_1_2_7_128_1
e_1_2_7_105_1
e_1_2_7_8_1
e_1_2_7_124_1
e_1_2_7_101_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_82_1
e_1_2_7_63_1
e_1_2_7_44_1
e_1_2_7_86_1
e_1_2_7_67_1
e_1_2_7_48_1
e_1_2_7_29_1
e_1_2_7_117_1
e_1_2_7_113_1
e_1_2_7_51_1
e_1_2_7_70_1
e_1_2_7_93_1
Oristrell J (e_1_2_7_120_1) 2021; 17
e_1_2_7_24_1
e_1_2_7_55_1
e_1_2_7_74_1
e_1_2_7_97_1
e_1_2_7_20_1
e_1_2_7_78_1
e_1_2_7_132_1
e_1_2_7_5_1
e_1_2_7_106_1
e_1_2_7_129_1
e_1_2_7_9_1
e_1_2_7_102_1
e_1_2_7_125_1
e_1_2_7_17_1
e_1_2_7_62_1
e_1_2_7_81_1
e_1_2_7_121_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_66_1
e_1_2_7_85_1
e_1_2_7_47_1
e_1_2_7_89_1
e_1_2_7_28_1
Mocanu V (e_1_2_7_36_1) 2013; 117
e_1_2_7_118_1
e_1_2_7_114_1
e_1_2_7_73_1
e_1_2_7_110_1
e_1_2_7_50_1
e_1_2_7_92_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_77_1
e_1_2_7_54_1
e_1_2_7_96_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_58_1
e_1_2_7_39_1
Handono K (e_1_2_7_32_1) 2014; 46
e_1_2_7_6_1
e_1_2_7_107_1
e_1_2_7_80_1
e_1_2_7_126_1
e_1_2_7_103_1
e_1_2_7_18_1
e_1_2_7_84_1
e_1_2_7_122_1
e_1_2_7_61_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_88_1
Loucera C (e_1_2_7_119_1) 2021
e_1_2_7_65_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_69_1
e_1_2_7_27_1
Roth A (e_1_2_7_59_1) 2020
McGregor R (e_1_2_7_71_1) 2020
e_1_2_7_91_1
e_1_2_7_115_1
e_1_2_7_72_1
e_1_2_7_95_1
e_1_2_7_111_1
e_1_2_7_30_1
e_1_2_7_53_1
e_1_2_7_76_1
e_1_2_7_99_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_57_1
e_1_2_7_130_1
e_1_2_7_38_1
References_xml – volume: 9
  start-page: 276
  issue: 5
  year: 2021
  end-page: 292
  article-title: Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta‐analysis of aggregate data from randomised controlled trials
  publication-title: Lancet Diabetes Endocrinol
– volume: 173
  start-page: 2909
  issue: 5
  year: 2004
  end-page: 2912
  article-title: Cutting edge: 1,25‐Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression
  publication-title: J Immunol
– volume: 279
  start-page: 35798
  issue: 34
  year: 2004
  end-page: 35802
  article-title: Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice
  publication-title: J Biol Chem
– year: 2021
  article-title: Association of vitamin D deficiency with COVID‐19 infection severity: systematic review and meta‐analysis
  publication-title: Clin Endocrinol
– volume: 370
  year: 2020
  article-title: A living WHO guideline on drugs for COVID‐19
  publication-title: BMJ
– volume: 33
  start-page: 456
  issue: 3
  year: 2012
  end-page: 492
  article-title: The nonskeletal effects of vitamin D: an Endocrine Society Scientific statement
  publication-title: Endocr Rev
– volume: 38
  start-page: 2210
  issue: 8
  year: 2008
  end-page: 2218
  article-title: 1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells
  publication-title: Eur J Immunol
– volume: 9
  start-page: 1
  issue: 9
  year: 2017
  end-page: 13
  article-title: 1α, 25‐dihydroxyvitamin D3 attenuates TGF‐β‐induced pro‐fibrotic effects in human lung epithelial cells through inhibition of epithelial‐mesenchymal transition
  publication-title: Nutrients
– volume: 212
  year: 2021
  article-title: The relationship between 25(OH) vitamin D levels and COVID‐19 onset and disease course in Spanish patients
  publication-title: J Steroid Biochem Mol Biol.
– volume: 117
  start-page: 965
  issue: 4
  year: 2013
  end-page: 973
  article-title: Current status in vitamin D and regulatory T cells—immunological implications
  publication-title: Med‐Surg J
– volume: 15
  start-page: 87
  issue: 2
  year: 2015
  end-page: 103
  article-title: Type I interferons in infectious disease
  publication-title: Nat Rev Immunol
– volume: 102
  start-page: 2867
  issue: 23
  year: 2000
  end-page: 2872
  article-title: 1α,25‐Dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL
  publication-title: Circulation
– volume: 311
  start-page: 1770
  issue: 5768
  year: 2006
  end-page: 1773
  article-title: Toll‐like receptor triggering of a vitamin D‐mediated human antimicrobial response
  publication-title: Science
– volume: 39
  start-page: 3147
  issue: 11
  year: 2009
  end-page: 3159
  article-title: Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: differential role for PD‐L1
  publication-title: Eur J Immunol
– volume: 111
  start-page: 23
  issue: 1
  year: 2014
  end-page: 45
  article-title: A systematic review of vitamin D status in populations worldwide
  publication-title: Br J Nutr
– volume: 13
  start-page: 1186
  issue: 2
  year: 2016
  end-page: 1194
  article-title: Vitamin D/VDR signaling attenuates lipopolysaccharide‐induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier
  publication-title: Mol Med Rep
– volume: 17
  start-page: 1
  year: 2021
  end-page: 13
  article-title: Vitamin D supplementation and COVID‐19 risk: a population‐based, cohort study
  publication-title: J Endocrinol Invest.
– volume: 81
  start-page: 548
  issue: 2
  year: 2007
  end-page: 557
  article-title: Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists
  publication-title: J Virol
– volume: 21
  start-page: 428
  issue: 5
  year: 2015
  end-page: 433
  article-title: Is there any association between thrombosis and tissue factor pathway inhibitor levels in patients with vitamin D deficiency?
  publication-title: Clin Appl Thromb
– volume: 2020
  year: 2020
  article-title: COVID‐19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps
  publication-title: Mediators Inflamm
– volume: 321
  start-page: 1003
  issue: 10
  year: 2019
  end-page: 1005
  article-title: High‐dose vitamin D supplementation during pregnancy and asthma in offspring at the age of 6 years
  publication-title: JAMA
– volume: 5
  year: 2015
  article-title: Chronic activation of the renin‐angiotensin system induces lung fibrosis
  publication-title: Sci Rep
– volume: 203
  year: 2020
  article-title: Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID‐19: a pilot randomized clinical study
  publication-title: J Steroid Biochem Mol Biol
– volume: 25
  start-page: 564
  issue: 3
  year: 2014
  end-page: 572
  article-title: Suppression of iron‐regulatory hepcidin by vitamin D
  publication-title: J Am Soc Nephrol
– volume: 356
  year: 2017
  article-title: Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta‐analysis of individual participant data
  publication-title: BMJ
– volume: 6
  start-page: 231
  issue: 3
  year: 2009
  end-page: 243
  article-title: Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin
  publication-title: Cell Host Microbe
– volume: 74
  start-page: 170
  issue: 2
  year: 2008
  end-page: 179
  article-title: Calcium‐independent and 1,25(OH)2D3‐dependent regulation of the renin‐angiotensin system in 1α‐hydroxylase knockout mice
  publication-title: Kidney Int
– volume: 56
  start-page: 383
  issue: 3
  year: 2017
  end-page: 392
  article-title: Effect of prenatal versus postnatal vitamin D deficiency on pulmonary structure and function in mice
  publication-title: Am J Respir Cell Mol Biol
– volume: 13
  start-page: 404
  issue: 7
  year: 2016
  end-page: 417
  article-title: Vitamin D and cardiovascular disease prevention
  publication-title: Nat Rev Cardiol
– volume: 74
  start-page: 657
  issue: 2
  year: 1984
  end-page: 661
  article-title: 1α,25‐Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells
  publication-title: J Clin Invest
– volume: 50
  start-page: 278
  issue: 2
  year: 2020
  end-page: 280
  article-title: Pulmonary intravascular coagulation in COVID‐19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
  publication-title: J Thromb Thrombolysis
– volume: 8
  start-page: 420
  issue: 4
  year: 2020
  end-page: 422
  article-title: Pathological findings of COVID‐19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir Med
– volume: 14
  start-page: 561
  issue: 4
  year: 2020
  end-page: 565
  article-title: Vitamin D concentrations and COVID‐19 infection in UKbiobank
  publication-title: Diabetes Metab Syndr Clin Res Rev
– volume: 40
  start-page: 420
  issue: 5
  year: 2013
  end-page: 429
  article-title: Dysregulated renin‐angiotensin system contributes to acute lung injury caused by hind‐limb ischemia‐reperfusion in mice
  publication-title: Shock
– volume: 11
  start-page: 571
  issue: 4
  year: 2014
  end-page: 577
  article-title: Vitamin D deficiency at 16 to 20 weeks’ gestation is associated with impaired lung function and asthma at 6 years of age
  publication-title: Ann Am Thorac Soc
– volume: 52
  start-page: 7359
  issue: 10
  year: 2011
  end-page: 7364
  article-title: Vitamin D enhances corneal epithelial barrier function
  publication-title: Investig Ophthalmol Vis Sci
– volume: 106
  start-page: E1343
  issue: 3
  year: 2021
  end-page: E1353
  article-title: Vitamin D status in hospitalized patients with SARS‐CoV‐2 infection
  publication-title: J Clin Endocrinol Metab
– volume: 7
  start-page: 303
  year: 2014
  end-page: 309
  article-title: The relationship between vitamin D status and idiopathic lower‐extremity deep vein thrombosis
  publication-title: Int J Gen Med
– volume: 453
  start-page: 52
  year: 2017
  end-page: 67
  article-title: Vitamin D endocrinology on the cross‐road between immunity and metabolism
  publication-title: Mol Cell Endocrinol
– volume: 9
  start-page: 649
  issue: 11
  year: 2019
  article-title: Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis
  publication-title: Biomolecules
– volume: 52
  start-page: 69
  issue: 1
  year: 2017
  end-page: 76
  article-title: Protective effect of vitamin D against hyperoxia‐induced lung injury in newborn rats
  publication-title: Pediatr Pulmonol
– volume: 407
  start-page: 699
  issue: 4
  year: 2011
  end-page: 702
  article-title: 1,25‐dihydroxyvitamin D3 impairs NF‐κB activation in human naïve B cells
  publication-title: Biochem Biophys Res Commun
– volume: 58
  year: 2020
  article-title: Vascular occlusion by neutrophil extracellular traps in COVID‐19
  publication-title: EBioMedicine
– volume: 18
  start-page: 844
  issue: 4
  year: 2020
  end-page: 847
  article-title: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
  publication-title: J Thromb Haemost
– volume: 21
  start-page: 137
  issue: 1
  year: 2020
  article-title: Local expression profiles of vitamin D‐related genes in airways of COPD patients
  publication-title: Respir Res.
– volume: 287
  start-page: 3693
  issue: 17
  year: 2020
  end-page: 3702
  article-title: Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
  publication-title: FEBS J
– volume: 119
  year: 2021
  article-title: The link between COVID‐19 and vitamin D (VIVID): a systematic review and meta‐analysis
  publication-title: Metabolism
– volume: 57
  start-page: 257
  issue: 3–4
  year: 1990
  end-page: 260
  article-title: 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants
  publication-title: Biol Neonate
– volume: 6
  year: 2015
  article-title: Glucocorticoids suppress inflammation via the upregulation of negative regulator Irak‐M
  publication-title: Nat Commun
– volume: 40
  start-page: 1109
  issue: 4
  year: 2019
  end-page: 1151
  article-title: Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions
  publication-title: Endocr Rev
– year: 2021
  article-title: Real world evidence of calcifediol prescription and mortality rate of COVID‐19 in a retrospective cohort of hospitalized Andalusian patients
  publication-title: MedRxiv
– volume: 325
  start-page: 1053
  issue: 11
  year: 2021
  end-page: 1060
  article-title: Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID‐19: a randomized clinical trial
  publication-title: JAMA
– volume: 89–90
  start-page: 387
  issue: 1–5
  year: 2004
  end-page: 392
  article-title: Vitamin D: a negative endocrine regulator of the renin‐angiotensin system and blood pressure
  publication-title: J Steroid Biochem Mol Biol
– volume: 63
  start-page: 79
  issue: 1
  year: 2020
  end-page: 91
  article-title: Maternal vitamin D deficiency causes sustained impairment of lung structure and function and increases susceptibility to hyperoxia‐induced lung injury in infant rats
  publication-title: Am J Respir Cell Mol Biol
– volume: 46
  start-page: 189
  issue: 3
  year: 2014
  end-page: 198
  article-title: Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus
  publication-title: Acta Med Indones
– volume: 16
  start-page: 1954
  issue: 11
  year: 2020
  end-page: 1955
  article-title: A potential treatment of COVID‐19 with TGF‐β blockade
  publication-title: Int J Biol Sci
– volume: 9
  issue: 5
  year: 2021
  article-title: Association of calcitriol supplementation with reduced COVID‐19 mortality in patients with chronic kidney disease: a population‐based study
  publication-title: Biomedicines
– volume: 8
  issue: 5
  year: 2012
  article-title: Vitamin D inhibits human immunodeficiency virus type 1 and mycobacterium tuberculosis infection in macrophages through the induction of autophagy
  publication-title: PLoS Pathog
– volume: 30
  start-page: 1367
  issue: 3
  year: 2016
  end-page: 1376
  article-title: Vitamin D modulates tissue factor and protease‐activated receptor 2 expression in vascular smooth muscle cells
  publication-title: FASEB J
– year: 2021
  article-title: Vitamin D actions: the lung is a major target for vitamin D and FGF23
  publication-title: JBMR Plus
– volume: 10
  start-page: 482
  issue: 4
  year: 2010
  end-page: 496
  article-title: Vitamin D: modulator of the immune system
  publication-title: Curr Opin Pharmacol
– volume: 27
  start-page: 933
  issue: 8
  year: 2011
  end-page: 941
  article-title: 1,25‐Dihydroxyvitamin D 3 alters murine dendritic cell behaviour in vitro and in vivo
  publication-title: Diabetes Metab Res Rev
– volume: 132
  start-page: 330
  issue: 2
  year: 2012
  end-page: 336
  article-title: Vitamin D receptor activation improves allergen‐triggered eczema in mice
  publication-title: J Invest Dermatol
– volume: 12
  start-page: 988
  issue: 4
  year: 2020
  article-title: Evidence that vitamin D supplementation could reduce risk of influenza and COVID‐19 infections and deaths
  publication-title: Nutrients
– volume: 4
  issue: 6
  year: 2009
  article-title: Convergence of IL‐1β and VDR activation pathways in human TLR2/1‐induced antimicrobial responses
  publication-title: PLoS One
– volume: 383
  start-page: 120
  issue: 2
  year: 2020
  end-page: 128
  article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID‐19
  publication-title: N Engl J Med
– volume: 21
  start-page: 89
  issue: 1
  year: 2020
  end-page: 116
  article-title: Consensus statement from 2nd International Conference on Controversies in Vitamin D
  publication-title: Rev Endocr Metab Disord
– volume: 437
  start-page: 7
  issue: 1
  year: 2013
  end-page: 11
  article-title: Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP‐1 and IL‐8 secretion in high‐glucose exposed U937 monocytes
  publication-title: Biochem Biophys Res Commun
– volume: 11
  start-page: 344
  issue: 4
  year: 2010
  end-page: 349
  article-title: Vitamin D controls T cell antigen receptor signaling and activation of human T cells
  publication-title: Nat Immunol
– volume: 117
  start-page: 803
  issue: 3
  year: 2007
  end-page: 811
  article-title: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D‐dependent mechanism
  publication-title: J Clin Invest
– volume: 24
  start-page: 69S
  issue: 9_suppl
  year: 2018
  end-page: 75S
  article-title: Low vitamin D levels are associated with the development of deep venous thromboembolic events in patients with ischemic stroke
  publication-title: Clin Appl Thromb
– volume: 558
  start-page: 136
  issue: 7708
  year: 2018
  end-page: 140
  article-title: Disruption of the beclin 1‐BCL2 autophagy regulatory complex promotes longevity in mice
  publication-title: Nature
– volume: 18
  start-page: 206
  issue: 1
  year: 2020
  article-title: Neutrophil‐to‐lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
  publication-title: J Transl Med
– volume: 170
  start-page: 5382
  issue: 11
  year: 2003
  end-page: 5390
  article-title: Differential regulation of vitamin D receptor and its ligand in human monocyte‐derived dendritic cells
  publication-title: J Immunol
– volume: 436
  start-page: 112
  issue: 7047
  year: 2005
  end-page: 116
  article-title: Angiotensin‐converting enzyme 2 protects from severe acute lung failure
  publication-title: Nature
– volume: 9
  issue: 6
  year: 2013
  article-title: Vitamin D induces interleukin‐1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection
  publication-title: PLoS Pathog
– year: 2020
  article-title: An autocrine vitamin D‐driven Th1 shutdown program can be exploited for COVID‐19
  publication-title: bioRxiv
– volume: 13
  issue: 6
  year: 2021
  article-title: Calcifediol treatment and hospital mortality due to COVID‐19: a cohort study
  publication-title: Nutrients.
– volume: 369
  start-page: 718
  issue: 6504
  year: 2020
  end-page: 724
  article-title: Impaired type I interferon activity and inflammatory responses in severe COVID‐19 patients
  publication-title: Science
– volume: 10
  start-page: 409
  issue: 4
  year: 2018
  article-title: Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta‐analysis
  publication-title: Nutrients
– volume: 44
  start-page: 465
  issue: 3
  year: 2012
  end-page: 468
  article-title: Angiotensin signalling in pulmonary fibrosis
  publication-title: Int J Biochem Cell Biol
– volume: 5
  start-page: 290
  issue: 1
  year: 2020
  article-title: Drug repurposing for COVID‐19 using machine learning and mechanistic models of signal transduction circuits related to SARS‐CoV‐2 infection
  publication-title: Signal Transduct Target Ther
– volume: 9
  start-page: e14
  issue: 2
  year: 2021
  end-page: e15
  article-title: Assessing the importance of interleukin‐6 in COVID‐19 – Authors’ reply
  publication-title: Lancet Respir Med
– volume: 16
  start-page: 7432
  issue: 5
  year: 2017
  end-page: 7438
  article-title: Vitamin D alleviates lipopolysaccharide‐induced acute lung injury via regulation of the renin‐angiotensin system
  publication-title: Mol Med Rep
– volume: 7
  start-page: 3011
  issue: 4
  year: 2015
  end-page: 3021
  article-title: Vitamin D and 1,25(OH)2D regulation of T cells
  publication-title: Nutrients
– volume: 15
  issue: 9
  year: 2020
  article-title: Vitamin D sufficiency, a serum 25‐hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID‐19 infection
  publication-title: PLoS One
– volume: 5
  issue: 1
  year: 2021
  article-title: Vitamin D and immune regulation: antibacterial, antiviral, anti‐inflammatory
  publication-title: JBMR Plus
– volume: 5
  issue: 17
  year: 2020
  article-title: Cytokine profile in plasma of severe COVID‐19 does not differ from ARDS and sepsis
  publication-title: JCI Insight
– volume: 155
  year: 2021
  article-title: Promising role of defensins peptides as therapeutics to combat against viral infection
  publication-title: Microb Pathog
– volume: 357
  start-page: 266
  issue: 3
  year: 2007
  end-page: 281
  article-title: Vitamin D deficiency
  publication-title: N Engl J Med
– volume: 278
  start-page: 46862
  issue: 47
  year: 2003
  end-page: 46868
  article-title: Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm
  publication-title: J Biol Chem
– volume: 9
  start-page: 622
  issue: 6
  year: 2021
  end-page: 642
  article-title: The COVID‐19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
  publication-title: Lancet Respir Med
– volume: 579
  start-page: 270
  issue: 7798
  year: 2020
  end-page: 273
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
– volume: 162
  start-page: 1
  issue: 2
  year: 2021
  end-page: 18
  article-title: Vitamin D‐regulated gene expression profiles: species‐specificity and cell‐specific effects on metabolism and immunity
  publication-title: Endocrinology
– volume: 85
  start-page: 78
  year: 2017
  end-page: 97
  article-title: Modulation of inflammatory and immune responses by vitamin D
  publication-title: J Autoimmun
– volume: 17
  start-page: 233
  issue: 4
  year: 2017
  end-page: 247
  article-title: Immune regulation by glucocorticoids
  publication-title: Nat Rev Immunol
– volume: 183
  start-page: R133
  issue: 5
  year: 2020
  end-page: R147
  article-title: Mechanisms in endocrinology vitamin D and COVID‐19
  publication-title: Eur J Endocrinol
– volume: 28
  start-page: 3125
  issue: 11
  year: 2021
  end-page: 3139
  article-title: Patients with COVID‐19: in the dark‐NETs of neutrophils
  publication-title: Cell Death Differ
– volume: 15
  issue: 9
  year: 2020
  article-title: SARS‐CoV‐2 positivity rates associated with circulating 25‐hydroxyvitamin D levels
  publication-title: PLoS One
– volume: 294
  start-page: G208
  issue: 1
  year: 2007
  end-page: G216
  article-title: Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 84
  start-page: 814
  issue: 10
  year: 2006
  end-page: 820
  article-title: Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
  publication-title: J Mol Med
– volume: 90
  year: 2021
  article-title: Neutrophils and COVID‐19: the road so far
  publication-title: Int Immunopharmacol
– volume: 106
  start-page: e4017
  issue: 10
  year: 2021
  end-page: e4027
  article-title: Calcifediol treatment and COVID‐19‐related outcomes
  publication-title: J Clin Endocrinol Metab
– volume: 95
  start-page: 3368
  issue: 7
  year: 2010
  end-page: 3376
  article-title: Vitamin D‐binding protein directs monocyte responses to 25‐hydroxy‐ and 1,25‐dihydroxyvitamin D
  publication-title: J Clin Endocrinol Metab
– volume: 584
  start-page: 430
  issue: 7821
  year: 2020
  end-page: 436
  article-title: Factors associated with COVID‐19‐related death using OpenSAFELY
  publication-title: Nature
– volume: 89–90
  start-page: 93
  issue: 1–5
  year: 2004
  end-page: 97
  article-title: 1,25‐Dihydroxyvitamin D3 and fetal lung maturation: immunogold detection of VDR expression in pneumocytes type II cells and effect on fructose 1,6 bisphosphatase
  publication-title: J Steroid Biochem Mol Biol
– volume: 177
  year: 2020
  article-title: Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF‐β induced epithelial to mesenchymal transition
  publication-title: Biochem Pharmacol
– volume: 11
  start-page: 184
  issue: 1
  year: 2021
  article-title: The causal role of circulating vitamin D concentrations in human complex traits and diseases: a large‐scale Mendelian randomization study
  publication-title: Sci Rep
– year: 2020
  article-title: LL‐37 fights SARS‐CoV‐2: the vitamin D‐inducible peptide LL‐37 inhibits binding of SARS‐CoV‐2 spike protein to its cellular receptor angiotensin converting enzyme 2 in vitro
  publication-title: BioRxiv
– volume: 167
  start-page: 183
  issue: 1
  year: 2016
  end-page: 191
  article-title: Therapeutic targeting of acute lung injury and acute respiratory distress syndrome
  publication-title: Transl Res
– volume: 451
  start-page: 142
  issue: 1
  year: 2014
  end-page: 147
  article-title: 1,25‐Dyhydroxyvitamin D3 attenuates rotenone‐induced neurotoxicity in SH‐SY5Y cells through induction of autophagy
  publication-title: Biochem Biophys Res Commun
– volume: 17
  start-page: 163
  issue: 1
  year: 2019
  article-title: 1,25‐(OH)2D3/vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
  publication-title: Cell Commun Signal
– volume: 395
  start-page: 1033
  issue: 10229
  year: 2020
  end-page: 1034
  article-title: COVID‐19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
– volume: 6
  start-page: 1
  issue: 4
  year: 2018
  end-page: 13
  article-title: Vitamin D receptor deletion leads to the destruction of tight and adherens junctions in lungs
  publication-title: Tissue Barriers
– volume: 11
  issue: 1
  year: 2021
  article-title: Evidence of a dysregulated vitamin D endocrine system in SARS‐CoV‐2 infected patient's lung cells
  publication-title: Sci Rep
– volume: 10
  issue: 1
  year: 2019
  article-title: SKP2 attenuates autophagy through Beclin1‐ubiquitination and its inhibition reduces MERS‐coronavirus infection
  publication-title: Nat Commun
– volume: 11
  start-page: 1137
  year: 2020
  article-title: Cathelicidins modulate TLR‐activation and inflammation
  publication-title: Front Immunol.
– volume: 92
  start-page: 1666
  issue: 12
  year: 2012
  end-page: 1669
  article-title: Beyond the RAAS: dissecting the antifibrotic effects of vitamin D analogues
  publication-title: Lab Invest
– volume: 141
  start-page: 14
  year: 2019
  end-page: 22
  article-title: 1,25‐Dihydroxyvitamin D3 induces formation of neutrophil extracellular trap‐like structures and modulates the transcription of genes whose products are neutrophil extracellular trap‐associated proteins: a pilot study
  publication-title: Steroids
– volume: 56
  issue: 4
  year: 2020
  article-title: Endothelial to mesenchymal transition: a precursor to post‐COVID‐19 interstitial pulmonary fibrosis and vascular obliteration?
  publication-title: Eur Respir J
– volume: 24
  start-page: 335
  issue: 3
  year: 2002
  end-page: 347
  article-title: Human neutrophils express messenger RNA of vitamin D receptor and respond to 1α,25‐dihydroxyvitamin D3
  publication-title: Immunopharmacol Immunotoxicol
– volume: 21
  start-page: 37
  issue: 1
  year: 2006
  end-page: 47
  article-title: Immune regulation of 25‐hydroxyvitamin‐D3‐1α‐hydroxylase in human monocytes
  publication-title: J Bone Miner Res
– volume: 185
  start-page: 1412
  issue: 3
  year: 2010
  end-page: 1418
  article-title: Critical role for TNF in the induction of human antigen‐specific regulatory T cells by tolerogenic dendritic cells
  publication-title: J Immunol
– volume: 110
  start-page: 21
  issue: 1
  year: 2021
  end-page: 26
  article-title: Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19
  publication-title: J Leukoc Biol
– volume: 12
  issue: 5
  year: 2020
  article-title: Vitamin D's effect on immune function
  publication-title: Nutrients
– volume: 319
  start-page: 698
  issue: 7
  year: 2018
  end-page: 710
  article-title: Acute respiratory distress syndrome advances in diagnosis and treatment
  publication-title: JAMA
– volume: 4
  start-page: 947
  issue: 7
  year: 2008
  end-page: 948
  article-title: Beclin 1 bridges autophagy, apoptosis and differentiation
  publication-title: Autophagy
– volume: 6
  issue: 8
  year: 2020
  article-title: Toll‐like receptors and COVID‐19: a two‐faced story with an exciting ending
  publication-title: Future Sci OA
– volume: 202
  year: 2020
  article-title: Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS‐CoV‐2 infections: Revised Ms SBMB 2020_166
  publication-title: J Steroid Biochem Mol Biol
– ident: e_1_2_7_83_1
  doi: 10.1186/s12964-019-0488-2
– volume: 7
  start-page: 303
  year: 2014
  ident: e_1_2_7_12_1
  article-title: The relationship between vitamin D status and idiopathic lower‐extremity deep vein thrombosis
  publication-title: Int J Gen Med
– ident: e_1_2_7_47_1
  doi: 10.1001/jama.2019.0052
– year: 2020
  ident: e_1_2_7_71_1
  article-title: An autocrine vitamin D‐driven Th1 shutdown program can be exploited for COVID‐19
  publication-title: bioRxiv
– ident: e_1_2_7_64_1
  doi: 10.1038/nri3787
– ident: e_1_2_7_53_1
  doi: 10.1016/j.bcp.2020.113955
– ident: e_1_2_7_63_1
  doi: 10.4161/auto.6787
– ident: e_1_2_7_86_1
  doi: 10.1002/JLB.5HI0720-466R
– ident: e_1_2_7_110_1
  doi: 10.1111/febs.15495
– ident: e_1_2_7_117_1
  doi: 10.3390/nu13061760
– ident: e_1_2_7_128_1
  doi: 10.1056/NEJMra070553
– ident: e_1_2_7_116_1
  doi: 10.1111/cen.14540
– ident: e_1_2_7_54_1
  doi: 10.1136/bmj.i6583
– year: 2020
  ident: e_1_2_7_59_1
  article-title: LL‐37 fights SARS‐CoV‐2: the vitamin D‐inducible peptide LL‐37 inhibits binding of SARS‐CoV‐2 spike protein to its cellular receptor angiotensin converting enzyme 2 in vitro
  publication-title: BioRxiv
– ident: e_1_2_7_111_1
  doi: 10.1210/clinem/dgaa733
– year: 2021
  ident: e_1_2_7_119_1
  article-title: Real world evidence of calcifediol prescription and mortality rate of COVID‐19 in a retrospective cohort of hospitalized Andalusian patients
  publication-title: MedRxiv
– ident: e_1_2_7_10_1
  doi: 10.1017/S0007114513001840
– ident: e_1_2_7_43_1
  doi: 10.1159/000243200
– ident: e_1_2_7_51_1
  doi: 10.1080/21688370.2018.1540904
– ident: e_1_2_7_106_1
  doi: 10.1016/S2213-2600(20)30076-X
– ident: e_1_2_7_85_1
  doi: 10.1038/s41586-018-0162-7
– ident: e_1_2_7_90_1
  doi: 10.1016/j.ebiom.2020.102925
– ident: e_1_2_7_87_1
  doi: 10.1186/s12967-020-02374-0
– ident: e_1_2_7_58_1
  doi: 10.3390/nu12040988
– ident: e_1_2_7_81_1
  doi: 10.3892/mmr.2017.7546
– ident: e_1_2_7_11_1
  doi: 10.1007/s11154-019-09532-w
– ident: e_1_2_7_129_1
  doi: 10.1038/s41598-021-87703-z
– ident: e_1_2_7_55_1
  doi: 10.1016/S2213-8587(21)00051-6
– ident: e_1_2_7_88_1
  doi: 10.1155/2020/8829674
– ident: e_1_2_7_123_1
  doi: 10.1016/j.jsbmb.2020.105751
– ident: e_1_2_7_35_1
  doi: 10.3390/nu7043011
– ident: e_1_2_7_101_1
  doi: 10.7150/ijbs.46891
– ident: e_1_2_7_69_1
  doi: 10.1172/jci.insight.140289
– ident: e_1_2_7_132_1
  doi: 10.3390/nu10040409
– ident: e_1_2_7_89_1
  doi: 10.1038/s41418-021-00805-z
– ident: e_1_2_7_109_1
  doi: 10.1371/journal.pone.0239252
– ident: e_1_2_7_23_1
  doi: 10.1016/j.bbrc.2013.06.004
– ident: e_1_2_7_82_1
  doi: 10.1074/jbc.M306340200
– ident: e_1_2_7_7_1
  doi: 10.1038/nrcardio.2016.73
– ident: e_1_2_7_77_1
  doi: 10.1016/j.jsbmb.2004.03.004
– ident: e_1_2_7_93_1
  doi: 10.1111/jth.14768
– ident: e_1_2_7_28_1
  doi: 10.1002/eji.200839103
– ident: e_1_2_7_125_1
  doi: 10.1136/bmj.m3379
– ident: e_1_2_7_18_1
  doi: 10.3389/fimmu.2020.01137
– ident: e_1_2_7_76_1
  doi: 10.1038/s41586-020-2012-7
– ident: e_1_2_7_80_1
  doi: 10.1097/SHK.0b013e3182a6953e
– ident: e_1_2_7_41_1
  doi: 10.1016/j.jsbmb.2004.03.054
– ident: e_1_2_7_16_1
  doi: 10.1126/science.1123933
– ident: e_1_2_7_118_1
  doi: 10.1210/clinem/dgab405
– ident: e_1_2_7_19_1
  doi: 10.1172/JCI30142
– ident: e_1_2_7_8_1
  doi: 10.3390/biom9110649
– ident: e_1_2_7_96_1
  doi: 10.1074/jbc.M404865200
– volume: 117
  start-page: 965
  issue: 4
  year: 2013
  ident: e_1_2_7_36_1
  article-title: Current status in vitamin D and regulatory T cells—immunological implications
  publication-title: Med‐Surg J
– ident: e_1_2_7_91_1
  doi: 10.1016/j.intimp.2020.107233
– ident: e_1_2_7_6_1
  doi: 10.1002/jbm4.10569
– ident: e_1_2_7_75_1
  doi: 10.1007/s00109-006-0094-9
– ident: e_1_2_7_27_1
  doi: 10.4049/jimmunol.1000560
– ident: e_1_2_7_3_1
  doi: 10.1210/er.2012-1000
– ident: e_1_2_7_78_1
  doi: 10.3892/mmr.2015.4685
– ident: e_1_2_7_25_1
  doi: 10.1016/j.jaut.2017.07.007
– ident: e_1_2_7_40_1
  doi: 10.1002/eji.200838216
– ident: e_1_2_7_102_1
  doi: 10.3390/nu9090980
– ident: e_1_2_7_44_1
  doi: 10.1165/rcmb.2014-0482OC
– ident: e_1_2_7_45_1
  doi: 10.1165/rcmb.2019-0295OC
– ident: e_1_2_7_113_1
  doi: 10.1371/journal.pone.0239799
– ident: e_1_2_7_114_1
  doi: 10.1016/j.dsx.2020.04.050
– ident: e_1_2_7_65_1
  doi: 10.1128/JVI.01782-06
– ident: e_1_2_7_66_1
  doi: 10.2144/fsoa-2020-0091
– ident: e_1_2_7_72_1
  doi: 10.1038/nri.2017.1
– ident: e_1_2_7_100_1
  doi: 10.1183/13993003.03167-2020
– ident: e_1_2_7_56_1
  doi: 10.1016/j.jsbmb.2020.105719
– ident: e_1_2_7_95_1
  doi: 10.1161/01.CIR.102.23.2867
– ident: e_1_2_7_42_1
  doi: 10.1186/s12931-020-01405-0
– ident: e_1_2_7_46_1
  doi: 10.1513/AnnalsATS.201312-423OC
– ident: e_1_2_7_84_1
  doi: 10.1038/s41467-019-13659-4
– ident: e_1_2_7_105_1
  doi: 10.1038/labinvest.2012.150
– ident: e_1_2_7_122_1
  doi: 10.1001/jama.2020.26848
– ident: e_1_2_7_13_1
  doi: 10.3390/nu12051248
– ident: e_1_2_7_38_1
  doi: 10.1172/JCI111465
– ident: e_1_2_7_49_1
  doi: 10.1167/iovs.11-7605
– ident: e_1_2_7_99_1
  doi: 10.1177/1076029613509477
– volume: 17
  start-page: 1
  year: 2021
  ident: e_1_2_7_120_1
  article-title: Vitamin D supplementation and COVID‐19 risk: a population‐based, cohort study
  publication-title: J Endocrinol Invest.
– ident: e_1_2_7_9_1
  doi: 10.1016/S2213-2600(21)00218-6
– ident: e_1_2_7_112_1
  doi: 10.1016/j.jsbmb.2021.105928
– ident: e_1_2_7_50_1
  doi: 10.1152/ajpgi.00398.2007
– ident: e_1_2_7_131_1
  doi: 10.1038/s41598-020-80655-w
– ident: e_1_2_7_79_1
  doi: 10.1038/ki.2008.101
– ident: e_1_2_7_107_1
  doi: 10.1001/jama.2017.21907
– ident: e_1_2_7_39_1
  doi: 10.1016/j.bbrc.2011.03.078
– ident: e_1_2_7_30_1
  doi: 10.4049/jimmunol.173.5.2909
– ident: e_1_2_7_61_1
  doi: 10.1371/journal.ppat.1002689
– ident: e_1_2_7_52_1
  doi: 10.1002/ppul.23500
– ident: e_1_2_7_70_1
  doi: 10.1016/S2213-2600(20)30603-2
– ident: e_1_2_7_121_1
  doi: 10.3390/biomedicines9050509
– ident: e_1_2_7_124_1
– ident: e_1_2_7_127_1
  doi: 10.1038/s41586-020-2521-4
– ident: e_1_2_7_60_1
  doi: 10.1016/j.chom.2009.08.004
– ident: e_1_2_7_104_1
  doi: 10.1016/j.biocel.2011.11.019
– ident: e_1_2_7_2_1
  doi: 10.1210/er.2018-00126
– ident: e_1_2_7_20_1
  doi: 10.1371/journal.ppat.1003407
– volume: 46
  start-page: 189
  issue: 3
  year: 2014
  ident: e_1_2_7_32_1
  article-title: Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus
  publication-title: Acta Med Indones
– ident: e_1_2_7_62_1
  doi: 10.1016/j.bbrc.2014.07.081
– ident: e_1_2_7_34_1
  doi: 10.1016/j.coph.2010.04.001
– ident: e_1_2_7_103_1
  doi: 10.1038/srep15561
– ident: e_1_2_7_15_1
  doi: 10.1210/jc.2010-0195
– ident: e_1_2_7_5_1
  doi: 10.1002/jbm4.10405
– ident: e_1_2_7_68_1
  doi: 10.1016/S0140-6736(20)30628-0
– ident: e_1_2_7_21_1
  doi: 10.1371/journal.pone.0005810
– ident: e_1_2_7_92_1
  doi: 10.1007/s11239-020-02129-0
– ident: e_1_2_7_4_1
  doi: 10.1210/endocr/bqaa218
– ident: e_1_2_7_94_1
  doi: 10.1056/NEJMoa2015432
– ident: e_1_2_7_57_1
  doi: 10.1530/EJE-20-0665
– ident: e_1_2_7_97_1
  doi: 10.1096/fj.15-272872
– ident: e_1_2_7_37_1
  doi: 10.1016/j.mce.2017.04.018
– ident: e_1_2_7_126_1
– ident: e_1_2_7_108_1
  doi: 10.1016/j.trsl.2015.04.015
– ident: e_1_2_7_17_1
  doi: 10.1016/j.micpath.2021.104930
– ident: e_1_2_7_22_1
  doi: 10.1681/ASN.2013040355
– ident: e_1_2_7_29_1
  doi: 10.1081/IPH-120014721
– ident: e_1_2_7_14_1
  doi: 10.4049/jimmunol.170.11.5382
– ident: e_1_2_7_33_1
  doi: 10.1038/ni.1851
– ident: e_1_2_7_98_1
  doi: 10.1177/1076029618786574
– ident: e_1_2_7_74_1
  doi: 10.1038/nature03712
– ident: e_1_2_7_48_1
  doi: 10.1038/jid.2011.296
– ident: e_1_2_7_73_1
  doi: 10.1038/ncomms7062
– ident: e_1_2_7_115_1
  doi: 10.1016/j.metabol.2021.154753
– ident: e_1_2_7_24_1
  doi: 10.1359/JBMR.050908
– ident: e_1_2_7_67_1
  doi: 10.1126/science.abc6027
– ident: e_1_2_7_31_1
  doi: 10.1016/j.steroids.2018.11.001
– ident: e_1_2_7_26_1
  doi: 10.1002/dmrr.1275
– ident: e_1_2_7_130_1
  doi: 10.1038/s41392-020-00417-y
SSID ssj0001783586
Score 2.267179
Snippet ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular...
Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular systems and...
ABSTRACT Preclinical data strongly suggest that the vitamin D endocrine system (VDES) may have extraskeletal effects. Cells of the immune and cardiovascular...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e10576
SubjectTerms 25-Hydroxyvitamin D
ACUTE RESPIRATORY DISTRESS SYNDROME
CALCIFEDIOL
Clinical trials
Coronaviruses
COVID-19
Dietary supplements
Endocrine system
Health care
Inflammation
INTENSIVE CARE TREATMENT
Lymphocytes
MORTALITY
Original
Respiratory distress syndrome
Tumor necrosis factor-TNF
VITAMIN D
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwEB2hrtggaAsECjICIRUpauJX7GWfKpUKG1p1F_kpiri-CNpFd3xCv7FfwthJo3vVCjZsoiiexXiOrZmxJ2cA3hkvDFdM1obiA1dIrA13vmYyk7dzFkxB-viTPDzhR2fibKHVV64JG-iBB8NtUcta7huvQ3QYzHOrjWfC2nx_pJ0qZNvo8xaSqXK6kg80lJz4SOnWNzvjpamtXPJAhaj_vujybpHkYvBavM_BY3g0ho1ke1D3CTwIaRXWthOmzLMr8p6UQs5yQr4Gm6eY78_OE9kj-8nPXf6_jwzM5MQkT3Y_n37cu_l93ep1ODnY_7J7WI8dEWqHgY2shYn5oo0rbRrUzAbfMOYap9oYLFrIam1bGb326He7YE0m2MMcTuAsdOg8eworaZ7CcyCOK9820XPlWgRHau8itZ0wPrYimq6CzVsr9W6kC89dK773A9Ex7bNF-2LRCt5Osj8Gkox7pXaysSeJTGxdPiDc_Qh3_y-4K9i4haofd9uvHrPA3KxCSFXBm2kY90m-_DApzC-LDKdUS0EreDYgO2nCeO6Fy9oKuiXMl1RdHknnXwsXt5KYj0ldwYeyOv4y_f5o55iXtxf_wxAv4SHN5TWlsmYDVi5-XoZXGB9d2NdlK_wB1r4Miw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9UwEB6VcuGCoGUJlMoIhFSkqIm3xBKXriqVChxo1VvkFVr1-aEuB278BH4jv4Sxk5fHExUSlyiKJ5E944lnxuNvAF5rJzRvmSw1xQvOkFBqbl3JZAJv58zrLOmjD_LgmB-eitMleDc7C9PjQ4wBt6QZ-X-dFFybq805aOi5mfBcpVbegbvpbG1Czqf80zzCkoIaudQj5Q1DR4mpEZ-Ubs5fX1iRMnD_bdbm30mTfxqzeTXafwD3BzOSbPVyfwhLPq7A6lZEF3rynbwhObEzR8xXYeME_f_JWSS7ZC-6qU3n_UiPVE50dGTn48n73V8_ftbqERzv733eOSiHCgmlRUNHlkKHtPHGW6Ur7JnxrmLMVratgzfKB6OUqWVwyuE63HijE-Ae-nQCR6F849hjWI7T6J8Csbx1dRUcb22NwpLK2UBNI7QLtQi6KWBjxqXODvDhqYrFRdcDH9MucbTLHC3g1Uj7rQfNuJVqOzF7pEhA1_nB9PJLN-hNRw2ruascDsaiL8eN0o4JY9L2obItfmRtJqpu0L6rDr3CVLxCyLaAl2Mz6k3aDNHRT28yDadUSUELeNJLduwJ46k2LqsLaBZkvtDVxZZ49jVjc7cS_TOpCnibZ8c_ht8dbh_xfPfsf4ifwz2a0mpyRs0aLF9f3vgXaBddm_U8_X8DPcUGVw
  priority: 102
  providerName: Wiley-Blackwell
Title Vitamin D Endocrine System and COVID‐19
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjbm4.10576
https://www.ncbi.nlm.nih.gov/pubmed/34950831
https://www.proquest.com/docview/2610315568
https://www.proquest.com/docview/2614229652
https://pubmed.ncbi.nlm.nih.gov/PMC8674769
https://doaj.org/article/2b314d0d9efc4954b9ad35bb68429c86
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VuPRStdBHWlgZtapEpYjEdpz4VLGwiCJBUVXQ3iK_Qqm6Xsrj0Ft_Qn8jvwSPkw2sirhEUTyKPDN2PK98A_BB2ULxiolU0XAJK6RJFTc2ZQLB2zlzKmr64FDsHfP9cTHuAm6XXVnl7JsYP9R2ajBGvhksfWxIUIjq8_nvFLtGYXa1a6GxAEsIXYYlXeW4vIuxYFijEj0qKd38qSc8trYVc-dQhOt_yMb8v1Tyvgkbz6Dd5_CsMx7JVqvtF_DE-WVY2fLBcZ78IR9JLOeMcfIV2DgJXv_kzJMdMvKBPfzLj7T45ER5S7a_nnzZufn7L5cv4Xh39H17L-36IqQmmDciLVSD6TZeSZWFmWlnM8ZMZqq8cVq6Rkupc9FYacPpWzqtEGYveHJF4EK60rJXsOin3r0BYnhl86yxvDJ5UJGQ1jRUl4WyTV40qkxgYyal2nSg4di74lfdwh3TGiVaR4km8L6nPW-hMh6kGqKwewqEt44PphendbdbaqpZzm1mAzMmeHBcS2VZoTUmDaWpwktWZ6qquz13Wd-tkATW--GwWzAForybXkcaTqkUBU3gdavZfiaMY0dclidQzul8bqrzI_7sR0TkrkTwyoRM4FNcHY-wX-8PD3i8e_s4D-_gKcXymVg5swqLVxfXbi3YP1d6AAuUHw3iUh_A0nB0ePRtEGMJt4fdB0A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V9gAXBJRHoIARD6lIURPHceIDQt3uVrttd0GorXpz_Uq7iM2WdivUGz-BX8KP4pdgO4-youqtlyiKR1Y8D3vGHn8D8EboVJA8oaHA9mE1pAgFUTpMqANvJ4kRXtLDEe3vka2D9GABfjd3YVxaZTMn-olaT5XbI1-znr4rSJDS_OPJ99BVjXKnq00JjUotts3FDxuynX0YdK1832K82dvd6Id1VYFQWeeAhqko3GEVyZmIjFbS6ChJVKTyuDCSmUIyJmNaaKbt2pUZKRxInY2DUq0MM5lObL-3YInY0diJYKnTG33-crmr4zZSctrioOK1r3JCfDFdOrfy-QIBV3m1_ydn_us0-1Vv8x7crd1VtF7p131YMOUDWF4vbag-uUDvkE8g9Tvzy7C6P56JybhEXdQrLUPdvUJUIaIjUWq08Wl_0P3z81fMHsLejfDsESyW09I8AaRIruOo0CRXsVUKyrQqsMxSoYs4LUQWwGrDJa5qmHJXLeMbrwCWMXcc5Z6jAbxuaU8qcI4rqTqO2S2FA9T2H6anR7y2T45lEhMdaTsYZWNGIpnQSSqlO6ZkKredrDSi4rWVn_FLnQzgVdts7dMduojSTM89DcGY0RQH8LiSbPsnCXE1eJM4gGxO5nO_Ot9Sjo89BnhObRxIWQDvvXZcM3y-1RkS__b0-jG8hNv93eEO3xmMtp_BHeySd3zezgoszk7PzXPrfc3ki1rlERzetJX9BdBxQ2U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIiEuCCiPlAJBPKQiRZv4lfiAUNvtqtvSwoFWe0v9hK3YbGm3Qr3xE_g9_Bx-CbbzKCuq3nqJotiy4nnYM-PxNwCvhKaCFJglArmHkxCbCKJ0gpkHbyfYiMDp3T22tU-2R3S0AL_buzA-rbJdE8NCrafKx8h7ztL3BQkoK3q2SYv41B-8P_6e-ApS_qS1LadRi8iOOf_h3LfTd8O-4_VrhAabnze2kqbCQKKcocASKqw_uCIFF6nRShqdYqxSVWTWSG6s5FxmzGqu3T6WGyk8YJ3ziahWhptcYzfuDbiZY5p5HctH-UV8x4dUCtYhoqLekZyQUFaXze2BoVTAZfbt_2ma_5rPYf8b3IU7jeEar9WSdg8WTHUfltYq57RPzuM3cUglDTH6JVg9GM_EZFzF_XizcqT1NwzjGhs9FpWONz4eDPt_fv7K-APYvxaKPYTFalqZxxArUugstZoUKnPiwbhWFsmcCm0zakUewWpLpVI1gOW-bsa3soZaRqWnaBkoGsHLru9xDdNxaa91T-yuh4fWDh-mJ1_KRlNLJHFGdKrdZJTzHonkQmMqpT-w5Kpwg6y0rCobfT8tL6Qzghdds9NUf_wiKjM9C30IQpxRFMGjmrPdn2Diq_HiLIJ8judzvzrfUo2_BjTwgjmPkPEI3gbpuGL65fb6Lglvy1fP4TnccrpVfhju7TyB28hn8YQEnhVYnJ2cmafODJvJZ0HeYzi8bgX7CznMRjU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vitamin+D+Endocrine+System+and+COVID%E2%80%9019&rft.jtitle=JBMR+plus&rft.au=Bouillon%2C+Roger&rft.au=Jos%C3%A9+Manuel+Quesada%E2%80%90Gomez&rft.date=2021-12-01&rft.pub=Oxford+University+Press&rft.eissn=2473-4039&rft.volume=5&rft.issue=12&rft_id=info:doi/10.1002%2Fjbm4.10576&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2473-4039&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2473-4039&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2473-4039&client=summon